+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

South America Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Product, and End User

  • PDF Icon

    Report

  • 73 Pages
  • September 2022
  • The Insight Partners
  • ID: 5668543
UP TO OFF until Mar 31st 2024
The hemodialysis and peritoneal dialysis market in South America is expected to grow from US$ 8,059.69 million in 2022 to US$ 11,772.43 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

The increasing prevalence of chronic kidney disease (CKD) that demands promising diagnostic test options is among the factors contributing to the growth of the hemodialysis and peritoneal dialysis market in this region. The annual incidence of ESKD is 160 patients per million population, with hypertension and diabetes the most common causes/etiologies. For instance, ~29,929 patients with ESKD were on chronic dialysis, representing a prevalence rate of 673 patients per million population by the end of 2018; ~93.5% were on in-center/hospital hemodialysis and 6.5% on peritoneal dialysis. According to the American Society of Nephrology report, Argentina comprises dialysis units in hospitals and private settings. For instance, there are a total number of 597 dialysis centers in the country; 68% of these centers are government-owned, 63% are independent dialysis centers, and 26% are owned by foreign dialysis companies. Moreover, dialysis centers are covered by the patient's union health system or health insurance; however, the government is payable to such dialysis centers if the patient does not carry union or health insurance. The South & Central America hemodialysis and peritoneal dialysis market is segmented into Argentina, Brazil, and the Rest of South & Central America. The Rest of South & Central America comprises Chile, Colombia, Peru, and Ecuador. According to the National Institute of Health report, adults in need of RRT receive kidney transplantation, hemodialysis, or peritoneal dialysis in Chile. For instance, 95% of Chilean patients in need of RRT are currently treated with hemodialysis and 4.5% with peritoneal dialysis, with only a few patients receiving a transplant. In 2008, Ecuador's government recognized CKD as a catastrophic illness and, from 2012, committed to guaranteeing medical attention to CKD patients, including dialysis procedures in ESKD cases. Such factors positively influence conducting hemodialysis and peritoneal dialysis procedures in Ecuador, thus driving the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America hemodialysis and peritoneal dialysis market. The South America hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.

South America Hemodialysis and Peritoneal Dialysis Market Segmentation

The South America hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country.
  • Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share.
  • Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022.
  • Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022.
  • Based on country, the South America hemodialysis and peritoneal dialysis market is segmented into Brazil, Argentina, and the Rest of South America. The Rest of South America is expected to hold the largest market share in 2022.
Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Diaverum; Fresenius Medical Care AG & Co KGaA; and Rockwell Medical, Inc. are among the leading companies in the South America hemodialysis and peritoneal dialysis market.
Frequently Asked Questions about the South American Hemodialysis and Peritoneal Dialysis Market

What is the estimated value of the South American Hemodialysis and Peritoneal Dialysis Market?

The South American Hemodialysis and Peritoneal Dialysis Market was estimated to be valued at $8059.69 Million in 2022.

What is the growth rate of the South American Hemodialysis and Peritoneal Dialysis Market?

The growth rate of the South American Hemodialysis and Peritoneal Dialysis Market is 6.5%, with an estimated value of $11772.43 Million by 2028.

What is the forecasted size of the South American Hemodialysis and Peritoneal Dialysis Market?

The South American Hemodialysis and Peritoneal Dialysis Market is estimated to be worth $11772.43 Million by 2028.

Who are the key companies in the South American Hemodialysis and Peritoneal Dialysis Market?

Key companies in the South American Hemodialysis and Peritoneal Dialysis Market include Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., DaVita Inc., Dialife SA, Diaverum, Fresenius Medical Care AG & Co KGaA and Rockwell Medical, Inc..

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Hemodialysis and Peritoneal Dialysis Market - By Type
1.3.2 South & Central America Hemodialysis and Peritoneal Dialysis Market - By Product
1.3.3 South & Central America Hemodialysis and Peritoneal Dialysis Market - By End User
1.3.4 South & Central America Hemodialysis and Peritoneal Dialysis Market - By Country
2. South & Central America Hemodialysis and Peritoneal Dialysis Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Hemodialysis and Peritoneal Dialysis Market - Market Landscape
4.1 Overview
4.2 South & Central America PEST Analysis
4.3 Expert Opinion
5. South & Central America Hemodialysis and Peritoneal Dialysis Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Kidney Diseases
5.1.2 Diabetes Becoming More Common
5.2 Market Restraints
5.2.1 Risks and Complications with Dialysis
5.3 Market Opportunities
5.3.1 Patients Opting for Home Care Dialysis
5.4 Future Trends
5.4.1 Major Players Upcoming with Various Market Strategies
5.5 Impact Analysis
6. Haemodialysis and Peritoneal Dialysis Market- South & Central America Analysis
6.1 South & Central America Haemodialysis and Peritoneal Dialysis Market Revenue Forecast and Analysis
6.2 South & Central America Haemodialysis and Peritoneal Dialysis Market, By Country - Forecast and Analysis
7. South & Central America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028- by Type
7.1 Overview
7.2 South & Central America Haemodialysis and Peritoneal Dialysis Market, By Type, 2022 & 2028 (%)
7.3 Haemodialysis
7.3.1 Overview
7.3.2 Haemodialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Peritoneal Dialysis
7.4.1 Overview
7.4.2 Peritoneal Dialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
8. South & Central America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 - Product
8.1 Overview
8.2 South & Central America Haemodialysis and Peritoneal Dialysis Market Share by Product Segment - 2021 & 2028 (%)
8.3 Devices
8.3.1 Overview
8.3.2 Devices: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.4 Consumables
8.4.1 Overview
8.4.2 Consumables: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.5 Services
8.5.1 Overview
8.5.2 Services: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 - End User
9.1 Overview
9.2 South & Central America Haemodialysis and Peritoneal Dialysis Market Share by End User Segment - 2021 & 2028 (%)
9.3 Hospital-Based
9.3.1 Overview
9.3.2 Hospital-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9.4 Home-Based
9.4.1 Overview
9.4.2 Home-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 - Country Analysis
10.1 Overview
10.1.1 South and Central America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 Argentina Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Argentina Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.3 Argentina: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.1.4 Argentina: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028, By Product (US$ Million)
10.1.1.1.5 Argentina: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 Brazil: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Brazil: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.3 Brazil: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.2.4 Brazil: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028, By Product (US$ Million)
10.1.1.2.5 Brazil: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 Rest of South and Central America: Haemodialysis and Peritoneal Dialysis Market- Revenue and Forecast to 2028 (USD Mn)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South and Central America: Haemodialysis and Peritoneal Dialysis Market- Revenue and Forecast to 2028 (USD Mn)
10.1.1.3.3 Rest of South & Central America: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.3.4 Rest of South & Central America: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028, By Product (US$ Million)
10.1.1.3.5 Rest of South and Central America: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11. Hemodialysis and Peritoneal Dialysis Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Hemodialysis and Peritoneal Dialysis Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Fresenius Medical Care AG & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DaVita Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Baxter International Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 B. Braun Melsungen AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Diaverum
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Asahi Kasei Medical Co., Ltd.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Rockwell Medical, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Dialife SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Dialife SA
  • Diaverum
  • Fresenius Medical Care AG & Co KGaA
  • Rockwell Medical, Inc.